Lilly Doubles Down On Novel Pain Drugs With Confo Therapeutics Deal

Adds To Three Non-Opioid Candidates In Pipeline

Mar 02 2023

The deal means that Lilly now has four candidates in development against pain. • Source: Michael Vi / Shutterstock.com